Taipei Exchange - Delayed Quote TWD
Mercury Biopharmaceutical Corporation (6932.TWO)
13.80
+0.95
+(7.39%)
At close: April 25 at 2:52:17 PM GMT+8
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-34,710
-34,710
-42,145
-25,842
-4,783
Investing Cash Flow
108,651
108,651
-194,437
-185,395
-8,022
Financing Cash Flow
-50,518
-50,518
248,926
240,612
15,280
End Cash Position
68,006
68,006
44,294
31,936
2,561
Capital Expenditure
-11,099
-11,099
-13,571
-68,653
-7,511
Issuance of Capital Stock
7,172
7,172
250,000
200,000
15,974
Issuance of Debt
--
--
--
41,600
--
Repurchase of Capital Stock
-56,244
-56,244
--
--
--
Free Cash Flow
-45,809
-45,809
-55,716
-94,495
-12,294
12/31/2021 - 12/23/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
6677.TWO Anxo Pharmaceutical Co., Ltd.
18.25
+1.11%
6539.TWO DV Biomed Co., Ltd.
72.00
+0.70%
6483.TWO Original BioMedicals Co., Ltd.
12.50
+0.40%
4172.TWO InnoPharmax Inc.
15.70
+2.61%
6817.TWO Winston Medical Supply Co., Ltd.
97.00
+1.57%
6467.TWO TAHO Pharma
64.40
+11.61%
6620.TWO Handa Pharmaceuticals, Inc.
73.70
-2.12%
7561.TWO Bioray Biotech Co., Ltd
20.10
+0.25%
4132.TWO Golden Biotechnology Corporation
14.95
-0.33%
6621.TWO UniPharma Co., Ltd.
15.35
-3.15%